Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information

R Hamamoto, T Koyama, N Kouno, T Yasuda… - … hematology & oncology, 2022 - Springer
Abstract Since US President Barack Obama announced the Precision Medicine Initiative in
his New Year's State of the Union address in 2015, the establishment of a precision …

Bridging the Divide: A Review on the Implementation of Personalized Cancer Medicine

M Masucci, C Karlsson, L Blomqvist… - Journal of Personalized …, 2024 - mdpi.com
The shift towards personalized cancer medicine (PCM) represents a significant
transformation in cancer care, emphasizing tailored treatments based on the genetic …

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world

P Giacomini, F Valenti, M Allegretti, M Pallocca… - Journal of Translational …, 2023 - Springer
Abstract Background Molecular Tumor Boards (MTB) operating in real-world have
generated limited consensus on good practices for accrual, actionable alteration mapping …

Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer

G Ciliberto, M Canfora, I Terrenato, C Agnoletto… - Journal of Experimental …, 2022 - Springer
Abstract Background Molecular tumor boards (MTBs) match molecular alterations with
targeted anticancer drugs upon failure of the available therapeutic options. Special and local …

Software-tool support for collaborative, virtual, multi-site molecular tumor boards

MP Schapranow, F Borchert, N Bougatf, H Hund… - SN Computer …, 2023 - Springer
The availability of high-throughput molecular diagnostics builds the foundation for Molecular
Tumor Boards (MTBs). Although more fine-grained data is expected to support decision …